- Home
- / IPA
IPA
Stock Price
$0.5
2024-10-29
Market Capitalization
$15.1 M
2024-10-29
Revenue
$24.5 M
FY, 2025
IPA Summary
Company Summary
- Overview
- IPA (ImmunoPrecise Antibodies) is a therapeutic antibody discovery company. It offers target analysis and immunization, antibody discovery and characterization, developability profiling, antibody optimization and engineering, and preclinical services. In addition, the company develops AI technology for immunogenicity screening, epitope mapping, and clinical off-target analysis.
- Type
- Public
- Status
- Active
- Founded
- 1989
- HQ
- Fargo, ND, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Chip Wheelock, Chief Technology Officer
Debby Kruijsen, General Manager, ImmunoPrecise Antibodies Europe
Teri Otto, General Manager, ImmunoPrecise Antibodies Canada
LocationsView all
5 locations detected
Fargo, ND HQ
United States
4837 Amber Valley Pkwy S #11
Cambridge, MA
United States
One Broadway, 1 Broadway 14th floor
Victoria, BC
Canada
4464 Markham St #3204
Oss, NB
Netherlands
Kloosterstraat 9
Utrecht, UT
Netherlands
Alexander Numangebouw, Yalelaan 62
IPA Financials
Summary Financials
- Revenue (FY, 2025)
- $C24.5M
- Gross profit (FY, 2025)
- $C13.5M
- Net income (FY, 2025)
- ($C30.2M)
- Cash (FY, 2025)
- $C10.8M